Freenome

Outpacing cancer starts with early detection

South San Francisco, United States · Founded 2014 · $554.0M raised

Employees
501–1000
Founded
2014
Business Model
B2B
Total Funding
$554.0M
Last Round
$254.0M Series EFeb 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. Founded in 2014 and headquartered in Brisbane, California, Freenome uses a multiomics platform that analyzes genomic, epigenomic, and proteomic biomarkers—including tumor-derived cell-free DNA—combined with machine learning to produce actionable cancer screening results from a standard blood draw. The company's lead program targets colorectal cancer (PREEMPT CRC Study) with additional programs in lung and other cancers. In 2025, Freenome entered an exclusive license agreement with Exact Sciences for its colorectal cancer blood test and announced a $330M SPAC merger to go public.

Summary

Freenome is an Artificial Intelligence company based in South San Francisco, United States, founded in 2014. It has raised $554.0M in total across 2 rounds, most recently a $254.0M Series E round in Feb 2024. Investors include Roche, Perceptive Advisors and Bain Capital Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EFeb 2024
$254.0M

Sign up to see all 2 events

Funding: Series D through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Freenome on Indexed.vc
<a href="https://indexed.vc/companies/freenome"><img src="https://indexed.vc/api/badge/company/freenome" alt="Freenome on Indexed.vc" width="260" height="76" /></a>